Untreated hypertension in Russian 35-69 year olds - a cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
26
12
2019
accepted:
12
05
2020
entrez:
30
5
2020
pubmed:
30
5
2020
medline:
18
8
2020
Statut:
epublish
Résumé
The Russian Federation has among the highest rates of cardiovascular disease (CVD) in the world and a high rate of untreated hypertension remains an important risk factor. Understanding who is at greatest risk is important to inform approaches to primary prevention. 2,353 hypertensive 35-69 year olds were selected from a population-based study, Know Your Heart, conducted in Arkhangelsk and Novosibirsk, Russian Federation, 2015-2018. The associations between untreated hypertension and a range of co-variates related to socio-demographics, health, and health behaviours were examined. The age-standardised prevalence of untreated hypertension was 51.1% (95% CI 47.8-54.5) in males, 28.8% (25.4-32.5) in females, and 40.0% (37.5-42.5) overall. The factors associated with untreated hypertension relative to treated hypertension were younger ages, self-rated general health as very good-excellent, not being obese, no history of CVD events, no evidence of diabetes or chronic kidney disease, and not seeing a primary care doctor in the past year as well as problem drinking for women and working full time, lower education, and smoking for men. The study found relatively high prevalence of untreated hypertension, especially, in men. Recent initiatives to strengthen primary care provision and implementation of a general health check programme (dispansarisation) are promising, although further studies should evaluate other, potentially more effective strategies tailored to the particular circumstances of this population.
Sections du résumé
BACKGROUND
The Russian Federation has among the highest rates of cardiovascular disease (CVD) in the world and a high rate of untreated hypertension remains an important risk factor. Understanding who is at greatest risk is important to inform approaches to primary prevention.
METHODS
2,353 hypertensive 35-69 year olds were selected from a population-based study, Know Your Heart, conducted in Arkhangelsk and Novosibirsk, Russian Federation, 2015-2018. The associations between untreated hypertension and a range of co-variates related to socio-demographics, health, and health behaviours were examined.
RESULTS
The age-standardised prevalence of untreated hypertension was 51.1% (95% CI 47.8-54.5) in males, 28.8% (25.4-32.5) in females, and 40.0% (37.5-42.5) overall. The factors associated with untreated hypertension relative to treated hypertension were younger ages, self-rated general health as very good-excellent, not being obese, no history of CVD events, no evidence of diabetes or chronic kidney disease, and not seeing a primary care doctor in the past year as well as problem drinking for women and working full time, lower education, and smoking for men.
CONCLUSION
The study found relatively high prevalence of untreated hypertension, especially, in men. Recent initiatives to strengthen primary care provision and implementation of a general health check programme (dispansarisation) are promising, although further studies should evaluate other, potentially more effective strategies tailored to the particular circumstances of this population.
Identifiants
pubmed: 32470073
doi: 10.1371/journal.pone.0233801
pii: PONE-D-19-34971
pmc: PMC7259637
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0233801Subventions
Organisme : Wellcome Trust
ID : 100217
Pays : United Kingdom
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
BMC Public Health. 2012 Aug 31;12:723
pubmed: 22938046
Eur J Prev Cardiol. 2018 Nov;25(16):1725-1734
pubmed: 29635927
Eur Heart J. 2019 Jul 1;40(25):2006-2017
pubmed: 31041440
Wellcome Open Res. 2018 Jun 4;3:67
pubmed: 30123849
Eur J Prev Cardiol. 2018 Aug;25(12):1326-1340
pubmed: 29916723
PLoS Med. 2017 Dec 6;14(12):e1002459
pubmed: 29211726
J Public Health (Oxf). 2012 Mar;34 Suppl 1:i3-10
pubmed: 22363028
Risk Manag Healthc Policy. 2018 Nov 02;11:209-220
pubmed: 30464661
Eur J Epidemiol. 2012 Jan;27(1):15-25
pubmed: 22089423
BMJ Open. 2016 Feb 08;6(2):e010155
pubmed: 26857106
Lancet. 2019 Oct 5;394(10205):1231-1242
pubmed: 31488369
Blood Press. 2018 Dec;27(6):314-340
pubmed: 30380928
J Gen Intern Med. 2007 Nov;22(11):1596-602
pubmed: 17874169
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
Cardiovasc Diagn Ther. 2017 Apr;7(Suppl 1):S48-S54
pubmed: 28529922
Int J Epidemiol. 2019 Oct 1;48(5):1721-1726
pubmed: 31329929
BMJ. 2012 Jul 09;345:e3953
pubmed: 22777025
N Engl J Med. 2018 Apr 05;378(14):1291-1301
pubmed: 29527973
Prev Med Rep. 2016 May 17;4:81-6
pubmed: 27413665
Ann Intern Med. 2018 Jan 16;168(2):110-120
pubmed: 29277852
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986